Longitudinal Oral and Fecal Microbiome Alterations in Veterans With New Antidepressant Monotherapy for Major Depressive Disorder
Abstract: Major depressive disorder (MDD) is associated with a wide range of adverse outcomes. Though antidepressants are often implemented as first-line treatments for MDD, remission and response rates remain modest. It is possible the microbiome could play a role in antidepressant treatment effectiveness.